|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Islami F, Miller KD, Siegel RL, Fedewa SA,
Ward EM and Jemal A: Disparities in liver cancer occurrence in the
United States by race/ethnicity and state. CA Cancer J Clin.
67:273–289. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bruix J and Sherman M: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Xu XF, Xing H, Han J, Li ZL, Lau WY, Zhou
YH, Gu WM, Wang H, Chen TH, Zeng YY, et al: Risk factors, patterns,
and outcomes of late recurrence after liver resection for
hepatocellular carcinoma: A multicenter study from China. JAMA
Surg. 154:209–217. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang H, Han J, Xing H, Li Z, Schwartz ME,
Zhou Y, Chen T, Wang H, Gu W, Lau WY, et al: Sex difference in
recurrence and survival after liver resection for hepatocellular
carcinoma: A multicenter study. Surgery. 165:516–524.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bruix J, Takayama T, Mazzaferro V, Chau G,
Yang J, Kudo M, Cai J, Poon RT, Han K, Tak WY, et al: Adjuvant
sorafenib for hepatocellular carcinoma after resection or ablation
(STORM): A phase 3, randomised, double-blind, placebo-controlled
trial. Lancet Oncol. 16:1344–1354. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yeager MP and Rosenkranz KM: Cancer
recurrence after surgery. Region Anesth Pain Med. 35:483–484.
2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lee JW, Shahzad MMK, Lin YG, Armaiz-Pena
G, Mangala LS, Han H, Kim H, Nam EJ, Jennings NB, Halder J, et al:
Surgical stress promotes tumor growth in ovarian carcinoma. Clin
Cancer Res. 15:2695–2702. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wall T, Sherwin A, Ma D and Buggy DJ:
Influence of perioperative anaesthetic and analgesic interventions
on oncological outcomes: A narrative review. Br J Anaesth.
123:135–150. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kim R: Effects of surgery and anesthetic
choice on immunosuppression and cancer recurrence. J Transl Med.
16:8–13. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vasileiou I, Xanthos T, Koudouna E, Perrea
D, Klonaris C, Katsargyris A and Papadimitriou L: Propofol: A
review of its non-anaesthetic effects. Eur J Pharmacol. 605:1–8.
2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Irwin MG, Chung CKE, Ip KY and Wiles MD:
Influence of propofol-based total intravenous anaesthesia on
peri-operative outcome measures: A narrative review. Anaesthesia.
75:e90–e100. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhang J, Shan WF, Jin TT, Wu GQ, Xiong XX,
Jin HY and Zhu SM: Propofol exerts anti-hepatocellular carcinoma by
microvesicle-mediated transfer of miR-142-3p from macrophage to
cancer cells. J Transl Med. 12(279)2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zheng H, Fu Y and Yang T: Propofol
inhibits proliferation, migration, and invasion of hepatocellular
carcinoma cells by downregulating Twist. J Cell Biochem.
120:12803–12809. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu W and Liu N: Propofol inhibits lung
cancer A549 cell growth and epithelial-mesenchymal transition
process by upregulation of microRNA-1284. Oncol Res. 27:1–8.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Du Q, Zhang X, Zhang X, Wei M, Xu H and
Wang S: Propofol inhibits proliferation and epithelial-mesenchymal
transition of MCF-7 cells by suppressing miR-21 expression. Artif
Cells Nanomed Biotechnol. 47:1265–1271. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang YF, Li CS, Zhou Y and Lu XH: Effects
of propofol on colon cancer metastasis through STAT3/HOTAIR axis by
activating WIF-1 and suppressing Wnt pathway. Cancer Med.
9:1842–1854. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhu F, Li Q, Yang Y, Wang L and Wang J:
Propofol suppresses proliferation, migration, invasion and promotes
apoptosis by upregulating microRNA-140-5p in gastric cancer cells.
Onco Targets Ther. 12:10129–10138. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Huang H, Benzonana LL, Zhao H, Watts HR,
Perry NJ, Bevan C, Brown R and Ma D: Prostate cancer cell
malignancy via modulation of HIF-1α pathway with isoflurane and
propofol alone and in combination. Br J Cancer. 111:1338–1349.
2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gao Y, Yu X, Zhang F and Dai J: Propofol
inhibits pancreatic cancer progress under hypoxia via ADAM8. J
Hepatobiliary Pancreat Sci. 26:219–226. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Kushida A, Inada T and Shingu K:
Enhancement of antitumor immunity after propofol treatment in mice.
Immunopharm Immunot. 29:477–486. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang L, Wang N, Zhou S, Ye W, Jing G and
Zhang M: Propofol induces proliferation and invasion of gallbladder
cancer cells through activation of Nrf2. J Exp Clin Cancer Res.
31(66)2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ecimovic P, Murray D, Doran P and Buggy
DJ: Propofol and bupivacaine in breast cancer cell function in
vitro-role of the NET1 gene. Anticancer Res. 34:1321–1331.
2014.PubMed/NCBI
|
|
26
|
Masoud GN and Li W: HIF-1α pathway: Role,
regulation and intervention for cancer therapy. Acta Pharm Sin B.
5:378–389. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tang B, Zhao F, Qu Y and Mu D:
Hypoxia-inducible factor-1alpha: A promising target for tumor
therapy. Ai Zheng. 28:775–782. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Muñoz Sánchez J and Chánez Cárdenas ME:
The use of cobalt chloride as a chemical hypoxia model. J Appl
Toxicol. 39:556–570. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Albanese J, Martin C, Lacarelle B, Saux P,
Durand A and Gouin F: Pharmacokinetics of long-term propofol
infusion used for sedation in ICU patients. Anesthesiology.
73:214–217. 1990.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Coetzee JF, Glen JB, Wium CA and Boshoff
L: Pharmacokinetic model selection for target-controlled infusions
of propofol. Assessment of three parameter sets. Anesthesiology.
82:1328–1345. 1995.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kim R: Anesthetic technique and cancer
recurrence in oncologic surgery: Unraveling the puzzle. Cancer
Metastasis Rev. 36:159–177. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yang C, Gao J, Yan N, Wu B, Ren Y, Li H
and Liang J: Propofol inhibits the growth and survival of gastric
cancer cells in vitro through the upregulation of ING3. Oncol Rep.
37:587–593. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Brahimi-Horn MC, Bellot G and Pouysségur
J: Hypoxia and energetic tumour metabolism. Curr Opin Genet Dev.
21:67–72. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wilson GK, Tennant DA and McKeating JA:
Hypoxia inducible factors in liver disease and hepatocellular
carcinoma: Current understanding and future directions. J Hepatol.
61:1397–1406. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Liu Y, Yan W, Tohme S, Chen M, Fu Y, Tian
D, Lotze M, Tang D and Tsung A: Hypoxia induced HMGB1 and
mitochondrial DNA interactions mediate tumor growth in
hepatocellular carcinoma through Toll-like receptor 9. J Hepatol.
63:114–121. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ou W, Lv J, Zou X, Yao Y, Wu J, Yang J,
Wang Z and Ma Y: Propofol inhibits hepatocellular carcinoma growth
and invasion through the HMGA2-mediated Wnt/β-catenin pathway. Exp
Ther Med. 13:2501–2506. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Gong T, Ning X, Deng Z, Liu M, Zhou B,
Chen X, Huang S, Xu Y, Chen Z and Luo R: Propofol-induced
miR-219-5p inhibits growth and invasion of hepatocellular carcinoma
through suppression of GPC3-mediated Wnt/β-catenin signalling
activation. J Cell Biochem. 120:16934–16945. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sun Y and Sun H: Propofol exerts
anticancer activity on hepatocellular carcinoma cells by raising
lncRNA DGCR5. J Cell Physiol. 235:2963–2972. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Meng C, Song L, Wang J, Li D, Liu Y and
Cui X: Propofol induces proliferation partially via downregulation
of p53 protein and promotes migration via activation of the Nrf2
pathway in human breast cancer cell line MDA-MB-231. Oncol Rep.
37:841–848. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Li R, Huang Y and Lin J: Distinct effects
of general anesthetics on lung metastasis mediated by
IL-6/JAK/STAT3 pathway in mouse models. Nat Commun.
11(642)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Deegan CA, Murray D, Doran P, Ecimovic P,
Moriarty DC and Buggy DJ: Effect of anaesthetic technique on
oestrogen receptor-negative breast cancer cell function in vitro.
Brit J Anaesth. 103:685–690. 2009.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Da Silva-Diz V, Lorenzo-Sanz L,
Bernat-Peguera A, Lopez-Cerda M and Muñoz P: Cancer cell
plasticity: Impact on tumor progression and therapy response. Semin
Cancer Biol. 53:48–58. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Guan X: Cancer metastases: Challenges and
opportunities. Acta Pharm Sin B. 5:402–418. 2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Xu YB, Jiang W, Zhao FR, Li G, Du QH,
Zhang MY and Guo XG: Propofol suppresses invasion and induces
apoptosis of osteosarcoma cell in vitro via downregulation of
TGF-β1 expression. Eur Rev Med Pharmacol Sci. 20:1430–1435.
2016.PubMed/NCBI
|
|
45
|
Wigmore TJ, Mohammed K and Jhanji S:
Long-term survival for patients undergoing volatile versus IV
anesthesia for cancer surgery: A retrospective analysis.
Anesthesiology. 124:69–79. 2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Wu ZF, Lee MS, Wong CS, Lu CH, Huang YS,
Lin KT, Lou YS, Lin C, Chang YC and Lai HC: Propofol-based total
intravenous anesthesia is associated with better survival than
desflurane anesthesia in colon cancer surgery. Anesthesiology.
129:932–941. 2018.PubMed/NCBI View Article : Google Scholar
|
